COVID-19 clinical management and therapeutics - Evidence to Practice Webinar series – PAHO/WHO

Clinical Management and COVID-19 webinar

The Pan American Health Organization (PAHO) COVID-19 Incident Management Support Team (IMST) hosts webinars that cover topics related to the clinical management of COVID-19. The webinars present the latest evidence-informed clinical practice and research for the management of COVID-19 patients in the region of the Americas. 

Panelists: Global and national experts in communicable disease/COVID-19 clinical management and therapeutics.

Participants: Medical professionals from the region of the Americas. Technical focal points in the Ministries of Health (MoH), PAHO country offices, UN agencies and other interested organizations.  

Platform: Zoom with an online link to be provided for each webinar. 

Language: English and/or Spanish with simultaneous translation.

Events

 

Date

Event

Presenter/panelist

2 March 2021 

Dr. Jean-Claude Tardif 

2 March 2021 

Ongoing living update of COVID-19 therapeutic options: Summary of evidence

 

 

Dr. Ariel Izcovich

16 March 2021

Dr. Peter Horby

15 April 2021 

Evidence for pharmacological management of patients with COVID-19

Respiratory Management of patients with COVID-19

Infection prevention and control considerations for the initial approach of patients with COVID-19

 

 

Dr. Ariel Izcovich

Dr. Ojino Sosa

Dr. Joao Toledo

6 May 2021

Experience in the development and implementation of the national guidelines for the management of COVID-19 patients in Chile 

Update of the COVID-19 clinical management guide, Pan American Health Organization

Expert panel: Experience in the management of patients with Covid-19

Dr. Ignacio Newman

 

Dra. Marcela Torres

Dr. Ho Yeh Li (Brazil)
Dr. Fabián Jaimes (Colombia)
Dra. María Paz Acuña (Chile)
Dr. Ojino Sosa (Mexico)

Revisión sistemática viva sobre tratamientos farmacológicos para el tratamiento de pacientes con COVID-19

Revisión sistemática viva sobre tratamientos farmacológicos para el tratamiento de pacientes con COVID-19